Logo image
Sign in
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
Journal article   Peer reviewed

A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

Robert R. Recker, Charles T. Benson, Toshio Matsumoto, Michael A. Bolognese, Deborah A. Robins, Jahangir Alam, Alan Y. Chiang, Leijun Hu, John H. Krege, Hideaki Sowa, …
Journal of Bone and Mineral Research, Vol.30(2), pp.216-224
02/2015
PMID: 25196993

Details